How common is empty sella in neuro-ophthalmology patients not suspected of raised intracranial pressure
28 February 2025
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The study aimed to assess how common the presence of empty / partially empty sella is amongst neuro-ophthalmology patients undergoing magnetic resonance imaging (MRI) excluding for papilledema and raised intracranial pressure (ICP). The study retrospectively reviewed case records of consecutive...
Predicting visual prognosis of patients with methanol poisoning
4 February 2025
| Jonathan Chan
|
EYE - Neuro-ophthalmology
Symptoms of methanol poisoning often occur 12–24 hours after oral consumption, and visual symptoms are seen in approximately 50% of cases. This study aims to investigate the role of optic nerve diffusion status on cranio-orbital magnetic resonance imaging (MRI) in...
Does modern radiological imaging detect lesions associated with internuclear ophthalmoplegia?
30 January 2025
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective case review including all patients with a diagnosis of internuclear ophthalmoplegia (INO) presenting to two tertiary neuro-ophthalmology centres over a five-year period. The aim of the study was to assess the sensitivity of modern radiological...
What are the characteristics of patients reporting diplopia in giant cell arteritis?
4 December 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective study of individuals diagnosed with giant cell arteritis (GCA) consecutively over a six-year period at a single tertiary ophthalmic centre. The characteristics of binocular diplopia prior to GCA diagnosis was collected from medical records and...
Comparing retinal thickness in Parkinson’s disease, essential tremor and healthy controls
4 December 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
This study aimed to compare retinal findings in chronic essential tremor (ET), early Parkinson’s disease (PD) and healthy controls. Those recruited with ET had to have received a diagnosis a minimum of three years previous and those with PD had...
Predicting outcome for visual acuity in optic neuritis associated with multiple sclerosis
3 October 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective cohort study to evaluate key predictors of long-term high-contrast visual acuity following optic neuritis associated with multiple sclerosis. All patients coded as optic neuropathy and assessed by a neuro-ophthalmologist over a 10-year period were screened...
Acromegaly associated with enlargement of extraocular recti muscles
3 October 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
This retrospective case review aimed to evaluate the frequency and extent of extraocular muscle enlargement in cases of acromegaly at presentation. All new presentations of acromegaly diagnosis at a single tertiary centre over a five-year period were screened for inclusion....
Could idebenone by the solution for treating dominant optic atrophy?
3 September 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Dominant optic atrophy (DOA) is a disease of the retinal ganglion cells, with no current treatment options. In most cases, DOA is caused by a mutation in the OPA1 gene. The aim of this study was to evaluate the effect...
Longitudinal findings in children with neurofibromatosis type 1
3 September 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
This retrospective chart review evaluates the ophthalmologic findings of children with neurofibromatosis type 1 (NF1). Optic pathway gliomas (OPGs) are the most common tumours found in children with NF1. Findings are compared between eyes with and without optic pathway gliomas...
Case reports of neuro-visual consequences of mild COVID-19 in children
31 October 2023
| Claire Howard
|
EYE - Neuro-ophthalmology, EYE - General
|
COVID-19, Neurovisual manifestations, neuro-COVID19, opthalmoplegia, paediatric ophthalmology
Neuro-visual involvement has been reported in numerous patients with severe SARS-CoV-2 disease, mainly among adult patients. In children, such involvement has been reported in rare cases, often in those presenting with severe forms of COVID-19. The aim of this work...
Did the COVID-19 pandemic affect quality of life of patients newly diagnosed with intra-cranial hypertension?
3 April 2023
| Claire Howard
|
EYE - Neuro-ophthalmology, EYE - General
|
COVID-19, Idiopathic intracranial hypertension, pandemic, quality of life
Coronavirus disease 2019 (COVID-19) was identified as a global pandemic by the World Health Organization in March 2020. This article aimed to explore how the care of patients with idiopathic intra-cranial hypertension (IIH) was affected during the COVID-19 lockdown. The...
Lagophthalmos as a potential complication of COVID-19
1 February 2022
| Claire Howard
|
EYE - Neuro-ophthalmology, EYE - General
|
Bell’s palsy, COVID-19, anosmia, coronavirus, Lagophthalmos
Lagophthalmos is a condition associated with the inability to close the eyelids effectively, with the main cause being facial nerve palsy. The authors aimed to investigate whether lagophthalmos was associated with coronavirus infection (COVID-19) by comparing patients diagnosed with lagophthalmos...
